Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine

Known as: Allogeneic LMI Breast Cancer Vaccine 
A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Chiral nanostructuring of multivalent macrocycles in solution and on surfaces.
We describe the design and synthesis of a novel functionality-rich, homochiral macrocycle, possessing the overall molecular D2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2013
Highly Cited
2013
Heptyl α-D-mannosides grafted on a β-cyclodextrin core to interfere with Escherichia coli adhesion: an in vivo multivalent effect.
n-Heptyl α-D-mannoside (HM) has previously been identified as a nanomolar FimH antagonist able to prevent Escherichia coli… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Highly Cited
2012
Highly Cited
2012
Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid.
Cationic liposome-DNA (CL-DNA) complexes are being pursued as nonviral gene delivery systems for use in applications that include… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2012
Highly Cited
2012
Glycoside and peptide clustering around the octasilsesquioxane scaffold via photoinduced free-radical thiol-ene coupling. The observation of a striking glycoside cluster effect.
Two series of multivalent octasilsesquioxane glyco- and peptido-conjugates were synthesized using the photoinduced free-radical… Expand
2009
2009
Novel HIV‐1 clade B candidate vaccines designed for HLA‐B*5101+ patients protected mice against chimaeric ecotropic HIV‐1 challenge
Novel candidate HIV‐1 vaccines have been constructed, which are tailor‐designed for HLA‐B*5101+ patients infected with HIV‐1… Expand
Highly Cited
2006
Highly Cited
2006
Facile in situ preparation of biologically active multivalent glyconanoparticles.
Biologically active multivalent glyconanoparticles are prepared in an extremely simple method by reduction of well-defined… Expand
  • figure 1
  • figure 2
Highly Cited
2004
Highly Cited
2004
Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as…
Multivalent glycoclusters have the potential to become pharmaceuticals by virtue of their target specificity toward clinically… Expand
Highly Cited
2001
Highly Cited
2001
An efficient numerical solution for H2 static output feedback synthesis
This paper addresses the problem of static output feedback synthesis and focuses on H2 optimisation. The bilinear problem of… Expand
  • figure 1
Highly Cited
1972
Highly Cited
1972
INDUCTION OF IMMUNITY AND TOLERANCE IN VITRO BY HAPTEN PROTEIN CONJUGATES
  • M. Feldmann
  • The Journal of experimental medicine
  • 1972
    • Corpus ID: 15893872
Of many dinitrophenylated (DNP) protein conjugates tested, only DNP conjugated to polymerized flagellin (DNP-POL) (or the… Expand
  • figure 4
  • figure 6
  • figure 7
  • table IV
1972
1972
INDUCTION OF IMMUNITY AND TOLERANCE IN VITRO BY HAPTEN PROTEIN CONJUGATES
  • M. Feldmann
  • The Journal of experimental medicine
  • 1972
    • Corpus ID: 5855494
The capacity of dissociated spleen cell suspensions to be immunized by dinitrophenylated polymeric flagellin (DNP POL), in the… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE